Tuberculosis, Lung Infections, and Respiratory Care

Antimicrobial Stewardship in Respiratory Care

Antimicrobial stewardship in respiratory care is a critical strategy to optimize the use of antibiotics and other antimicrobial agents in the treatment of respiratory infections, aiming to improve patient outcomes while minimizing the emergence of drug resistance. Respiratory infections—ranging from community-acquired pneumonia and bronchitis to hospital-acquired infections and tuberculosis—often prompt antibiotic use, which, if inappropriate or excessive, can drive antimicrobial resistance, increase healthcare costs, and contribute to adverse drug reactions. Stewardship programs provide structured guidance on the selection, dosing, duration, and route of antimicrobial therapy based on evidence-based guidelines, local resistance patterns, and individual patient factors.

Effective antimicrobial stewardship in respiratory care combines diagnostic precision, clinical judgment, and multidisciplinary collaboration. Rapid diagnostic tools, including molecular assays and point-of-care tests, help distinguish bacterial from viral infections, reducing unnecessary antibiotic prescriptions. Regular review of ongoing treatments, de-escalation strategies, and targeted therapy for drug-resistant pathogens are central to stewardship efforts. Education of healthcare providers and patients, along with monitoring of antimicrobial use and resistance trends, reinforces appropriate prescribing practices.